| Display title | Chemistry:Mexazolam |
| Default sort key | Mexazolam |
| Page length (in bytes) | 5,300 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 806803 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>QCDvac |
| Date of page creation | 00:30, 6 February 2024 |
| Latest editor | imported>QCDvac |
| Date of latest edit | 00:30, 6 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Mexazolam (marketed under the trade names Melex and Sedoxil) is a drug which is a benzodiazepine derivative. Mexazolam has been trialed for anxiety and was found to be effective in alleviating anxiety at one week follow-up. Mexazolam is metabolised via the CYP3A4 pathway. HMG-CoA reductase inhibitors... |
